0001209191-14-033826.txt : 20140514
0001209191-14-033826.hdr.sgml : 20140514
20140514180556
ACCESSION NUMBER: 0001209191-14-033826
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140512
FILED AS OF DATE: 20140514
DATE AS OF CHANGE: 20140514
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: QUESTCOR PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000891288
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 330476164
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1300 NORTH KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
BUSINESS PHONE: 714-786-4200
MAIL ADDRESS:
STREET 1: 1300 NORTH KELLOGG DRIVE
STREET 2: SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
FORMER COMPANY:
FORMER CONFORMED NAME: CYPROS PHARMACEUTICAL CORP
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mulroy Michael H.
CENTRAL INDEX KEY: 0001509725
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-14758
FILM NUMBER: 14842943
MAIL ADDRESS:
STREET 1: 1300 N. KELLOGG DRIVE, SUITE D
CITY: ANAHEIM
STATE: CA
ZIP: 92807
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-05-12
0
0000891288
QUESTCOR PHARMACEUTICALS INC
QCOR
0001509725
Mulroy Michael H.
1300 NORTH KELLOGG DRIVE
SUITE D
ANAHEIM
CA
92807
0
1
0
0
See Remarks
Common Stock
2014-05-12
4
M
0
10000
14.24
A
87063
D
Common Stock
2014-05-12
4
S
0
5000
88.0103
D
82063
D
Common Stock
2014-05-12
4
S
0
5000
87.9713
D
77063
D
Stock Option (right to buy)
14.24
2014-04-10
4
M
0
10000
0.00
D
2021-02-15
Common Stock
10000
95000
D
Stock options granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan.
The option was granted on 02/16/2011 for the right to buy 125,000 shares of common stock of the Issuer. The option provided for monthly vesting over 48 months from the date of grant, with a 12-month cliff, whereby no options vested until after the twelfth month from the date of the grant.
The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $87.15-88.32 and 87.26-88.32, respectively. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
Title: EVP, Strategic Affairs and General Counsel
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan (the "Automatic Trading Plan") adopted by the reporting person in the second quarter of 2013 and effective 90 days post-adoption. There have been no changes to the Automatic Trading Plan since its adoption. The first sale under the Automatic Trading Plan occurred on March 10, 2014, and there have been no sales by the Reporting Person outside of the Automatic Trading Plan since its adoption. The Automatic Trading Plan controls the exact dates and amounts of sales.
/s/ Michael H. Mulroy
2014-05-14